Benfotiamine and Cognitive Decline in Alzheimer’s Disease: Results of a Randomized Placebo-Controlled Phase IIa Clinical Trial is a research paper published in Journal of Alzheimer s Disease (2020). On theSindex it has a DataRank of 0. It has been cited 103 times.
Scored on demand from live citation data
DataRank reads this dataset's downstream impact straight off the citation graph — no black box, no proprietary weighting. How is this computed?
FAIR checklist signals are shown for context only and do not affect DataRank scoring.
We only score data papers we can read in full — never from an abstract alone.
National Institutes of Health
Grant: 5R01AG043679-05
Benfotiamine in Alzheimer's Disease: A pilot study
National Institutes of Health
Grant: 3UL1TR000457-08S1
Clinical and Translational Science Center
National Institutes of Health
Grant: 5K24AG045334-05
Midcareer Award for Research in Dementia Risk Factors and Prevention
NIA NIH HHS
Grant: R56 AG062305
NIA NIH HHS
Grant: R01 AG062624
NCATS NIH HHS
Grant: UL1 TR002384
NCATS NIH HHS
Grant: UL1 TR000457
NIA NIH HHS
Grant: K24 AG045334
NIA NIH HHS
Grant: R01 AG043679
FWCI
7.64
Citation Percentile
1.0%
Citation Trend
Fields of Study
MeSH Terms
Keywords
Sustainable Development Goals